The Alliance for Trade Enforcement recently submitted comments to the U.S. Trade Representative for this year's Special 301, the Office's annual review to identify countries that deny adequate intellectual property protections or erect access barriers to America's innovative industries...
Did you know that an obscure Canadian agency called the "Patented Medicines Pricing Review Board" unilaterally sets below-market prices for breakthrough medicines developed by American scientists? Canada thus forces U.S. biopharmaceutical innovators...
Did you know that Korea continues to violate its obligations under KORUS to fairly reimburse U.S. biopharmaceutical manufacturers for their new cures and treatments? For example, KORUS requires Korea to set up an independent review process for pricing determinations of new drugs...
Welcome to the third edition of Spotlight on Enforcement, where every other week the Alliance for Trade Enforcement will highlight the various ways that other countries are not fulfilling their commitments to American companies and workers...